Opinion: The real threat to abortion meds is Trump himself
Opinion | The real threat to abortion meds is Trump himself
A unanimous court saved mifepristone. But more formidable challenges to abortion medication loom.
By Ruth Marcus
Associate editor
June 13, 2024 at 6:03 p.m. EDT
reathe a sigh of relief over the Supreme Courts decision to toss out a challenge to the abortion medication mifepristone. Then take a deep breath, because this isnt the end of efforts to interfere with access to medication abortion.
First, the good news and it is good, although it should never have been necessary. The justices found that antiabortion doctors and their medical organization lacked standing to bring a challenge to the Food and Drug Administrations moves to make it easier for women seeking abortions to obtain abortion medication, which now accounts for more than 60 percent of all abortions.
Notably for this court, the ruling in
FDA v. Alliance for Hippocratic Medicine was unanimous. The outcome is a sharp if implicit rebuke to the out-of-control U.S. Court of Appeals for the Fifth Circuit, which had
stretched tortured, really the law of standing to find that the doctors and their group, created in the wake of the courts 2022 ruling eliminating the constitutional right to abortion, could bring suit.
{snip}
Opinion by Ruth Marcus
Ruth Marcus is an associate editor and columnist for The Post. Twitter
https://twitter.com/RuthMarcus